News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
228,940 Results
Type
Article (8533)
Company Profile (115)
Press Release (220291)
Multimedia
Podcasts (70)
Webinars (12)
Section
Business (68766)
Career Advice (376)
Deals (13133)
Drug Delivery (32)
Drug Development (36763)
Employer Resources (72)
FDA (4225)
Job Trends (4761)
News (122419)
Policy (9444)
Tag
Academia (332)
Accelerated approval (2)
Adcomms (4)
Allergies (52)
Alliances (18227)
ALS (58)
Alzheimer's disease (564)
Antibody-drug conjugate (ADC) (133)
Approvals (4357)
Artificial intelligence (154)
Autoimmune disease (45)
Automation (6)
Bankruptcy (70)
Best Places to Work (3605)
BIOSECURE Act (16)
Biosimilars (94)
Biotechnology (75)
Bladder cancer (55)
Brain cancer (21)
Breast cancer (152)
Cancer (1544)
Cardiovascular disease (96)
Career advice (344)
Career pathing (26)
CAR-T (97)
CDC (12)
Cell therapy (234)
Cervical cancer (8)
Clinical research (32392)
Collaboration (592)
Compensation (542)
Complete response letters (23)
COVID-19 (799)
CRISPR (18)
C-suite (300)
Cystic fibrosis (37)
Data (2204)
Decentralized trials (1)
Denatured (13)
Depression (51)
Diabetes (124)
Diagnostics (1183)
Digital health (8)
Diversity (7)
Diversity, equity & inclusion (19)
Drug discovery (74)
Drug pricing (46)
Drug shortages (3)
Duchenne muscular dystrophy (78)
Earnings (29583)
Editorial (35)
Employer branding (10)
Employer resources (63)
Events (40601)
Executive appointments (454)
FDA (5242)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (439)
Gene editing (43)
Generative AI (14)
Gene therapy (150)
GLP-1 (340)
Government (977)
Grass and pollen (1)
Guidances (154)
Healthcare (3173)
HIV (20)
Huntington's disease (12)
IgA nephropathy (34)
Immunology and inflammation (69)
Immuno-oncology (12)
Indications (26)
Infectious disease (871)
Inflammatory bowel disease (74)
Inflation Reduction Act (8)
Influenza (25)
Intellectual property (80)
Interviews (62)
IPO (6833)
IRA (18)
Job creations (1209)
Job search strategy (273)
Kidney cancer (8)
Labor market (66)
Layoffs (174)
Leadership (27)
Legal (1722)
Liver cancer (34)
Longevity (2)
Lung cancer (267)
Lymphoma (127)
Machine learning (14)
Management (23)
Manufacturing (277)
MASH (95)
Medical device (1516)
Medtech (1519)
Mergers & acquisitions (6801)
Metabolic disorders (419)
Multiple sclerosis (60)
NASH (8)
Neurodegenerative disease (67)
Neuropsychiatric disorders (22)
Neuroscience (971)
NextGen: Class of 2025 (1155)
Non-profit (292)
Now hiring (49)
Obesity (191)
Opinion (100)
Ovarian cancer (48)
Pain (51)
Pancreatic cancer (56)
Parkinson's disease (83)
Partnered (6)
Patents (148)
Patient recruitment (150)
Peanut (18)
People (21002)
Pharmaceutical (40)
Pharmacy benefit managers (4)
Phase I (9676)
Phase II (14612)
Phase III (11022)
Pipeline (1497)
Policy (118)
Postmarket research (703)
Preclinical (3648)
Press Release (21)
Prostate cancer (60)
Psychedelics (17)
Radiopharmaceuticals (134)
Rare diseases (237)
Real estate (1667)
Recruiting (32)
Regulatory (8141)
Reports (30)
Research institute (369)
Resumes & cover letters (42)
RNA editing (4)
RSV (24)
Schizophrenia (91)
Series A (79)
Series B (51)
Service/supplier (5)
Sickle cell disease (19)
Special edition (23)
Spinal muscular atrophy (46)
Sponsored (6)
Startups (1263)
State (1)
Stomach cancer (3)
Supply chain (30)
Tariffs (44)
The Weekly (56)
Vaccines (256)
Venture capital (36)
Weight loss (85)
Women's health (15)
Worklife (14)
Date
Today (49)
Last 7 days (307)
Last 30 days (1581)
Last 365 days (12733)
2025 (11511)
2024 (14574)
2023 (16739)
2022 (21246)
2021 (22359)
2020 (19327)
2019 (12607)
2018 (9218)
2017 (11353)
2016 (9566)
2015 (12273)
2014 (9364)
2013 (7137)
2012 (7157)
2011 (7163)
2010 (6973)
Location
Africa (227)
Alabama (23)
Arizona (35)
Arkansas (2)
Asia (28998)
Australia (3619)
California (4119)
Canada (981)
China (724)
Colorado (142)
Connecticut (158)
Delaware (157)
Europe (34773)
Florida (538)
Georgia (125)
Idaho (4)
Illinois (203)
India (29)
Indiana (135)
Iowa (10)
Japan (246)
Kansas (75)
Kentucky (9)
Louisiana (2)
Maine (6)
Maryland (441)
Massachusetts (3243)
Michigan (45)
Minnesota (153)
Mississippi (2)
Missouri (31)
Nebraska (6)
Nevada (16)
New Hampshire (6)
New Jersey (1451)
New Mexico (7)
New York (1301)
North Carolina (536)
Northern California (2069)
Ohio (110)
Oklahoma (7)
Oregon (13)
Pennsylvania (724)
Puerto Rico (12)
Rhode Island (11)
South America (283)
South Carolina (5)
Southern California (1602)
Tennessee (16)
Texas (435)
United States (14370)
Utah (93)
Virginia (122)
Washington D.C. (24)
Washington State (262)
West Virginia (1)
Wisconsin (19)
228,940 Results for "redhill biopharma ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Quantum BioPharma Ltd. Announces Corporate Updates
October 30, 2025
·
11 min read
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
November 5, 2025
·
1 min read
·
Angela Gabriel
Opinion
A Flu Season in Flux Presents Risks, Opportunities for Biopharma
The coming flu season is the clearest indication yet that biopharma’s long-standing assumptions about predictability, prevention and portfolio structure are no longer guaranteed.
October 28, 2025
·
7 min read
·
Tom Sebok
C-suite
The 5 Most Powerful Women in Biopharma
As the industry loses one of its key female leaders in GSK CEO Emma Walmsley,
BioSpace
profiles the women leading the industry’s smaller biopharmas.
October 8, 2025
·
6 min read
·
Annalee Armstrong
Government
FDA Struggles To Keep Lights On Amid Shutdown as Biopharmas Begin To See Delays
While the FDA continues to put out guidance documents and approve drugs, some companies are already reporting delays in dealings with the agency, while insiders warn of falling morale and a negative perception from the rest of the biopharma world.
October 29, 2025
·
4 min read
·
Dan Samorodnitsky
Special edition
Deep Dive: Women in Biopharma
BioSpace
did a deep dive into biopharma female executives who navigated difficult markets to lead their companies to high-value exits.
August 27, 2025
·
1 min read
·
Annalee Armstrong
Deals
RedHill Biopharma Announces $8 Million Registered Direct Offering
RedHill Biopharma Ltd. investors for the purchase and sale of 10,000,000 of the Company’s American Depositary Shares (“ADSs”) at a purchase price of $0.80 per ADS, in a registered direct offering.
January 25, 2024
·
9 min read
Job search strategy
More Marathon Than Sprint: Getting Biopharma Jobs Often Takes 4+ Months,
BioSpace
Finds
Biopharma professionals aren’t typically hired right away, based on a
BioSpace
LinkedIn poll. In the past year, only about one-third of respondents found employment in three months or less. Several who did share their keys to success.
October 15, 2025
·
5 min read
·
Angela Gabriel
Bio NC
RedHill Biopharma Announces Closing of $8 Million Registered Direct Offering
RedHill Biopharma Ltd. announced that it has closed its previously announced registered direct offering for the purchase and sale of 10,000,000 of the Company’s American Depositary Shares, each ADS representing four hundred ordinary shares, at a purchase price of $0.80 per ADS.
January 26, 2024
·
9 min read
Employer Resources
Report: Driving Biopharma Engagement
Establishing trust through thought leadership is no longer optional in today’s cautious biopharma market. Learn how strategic insights and targeted outreach can turn awareness into high-converting leads.
August 11, 2025
·
1 min read
·
BioSpace Insights
1 of 22,894
Next
